ReWalk Personal Device Postmarket Study

计划入组 60 人 · 首次发布于 2016 年 10 月 26 日

The ReWalk Exoskeletal Walking System for Persons With Paraplegia

计划入组 19 人 · 首次发布于 2011 年 10 月 19 日

Safety and Performance Evaluation of ReWalk Reciprocating Gait Orthosis (RGO)

计划入组 32 人 · 首次发布于 2010 年 12 月 2 日

IND-006

Trabodenoson

C₁₅H₂₀N₆O₆

Masitinib

C₂₈H₃₀N₆OS

ReWalk Robotics, Inc.

United States

60 Pharmaceuticals LLC

United States

NEWARK BETH ISRAEL MEDICAL CENTER

United States

FDA Grants 510(k) Clearance for ReWalk 7 Exoskeleton for Spinal Cord Injury Patients

Lifeward Partners with CorLife to Expand Workers' Compensation Access to ReWalk Exoskeleton

Oramed and Lifeward Announce Strategic Merger Creating Diversified Biomedical Platform